NCS Multistage Holdings (NASDAQ:NCSM) reported quarterly earnings of $1.41 per share. This is a 452.5 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly
NCS Multistage Holdings, Inc. (NASDAQ:NCSM) (the "Company," "NCS," "we" or "us") today announced, effective November 3, 2022, its Board of Directors appointed Michael Morrison as
Contrary to 2021, when equity markets were in a bull run, 2022 has served as a not-so-gentle reminder that the stock market does not give free gifts. The macro attitude that is pushing the markets lower has been influenced by worries about a recession, geopolitical tensions, the energy crisis, and record inflation.
NCS Multistage Holdings (NASDAQ:NCSM) reported quarterly losses of $(0.93) per share. This is a 21.19 percent increase over losses of $(1.18) per share from the same period last year. The company reported quarterly
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
NCS Multistage Holdings (NASDAQ:NCSM) reported quarterly earnings of $0.48 per share. This is a 117.78 percent increase over losses of $(2.70) per share from the same period last year. The company reported quarterly
Companies Reporting Before The Bell
• Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.